INTERPACE BIOSCIENCES, INC. — insider transactions

6 transactions on record · CIK 1054102

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
6
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
2
Bought, 3m
$0
Sold, 3m
$936.6K
Median disclosure lag
0.0 d
trade date to filing date
Largest single trade, 24m
$936.6K
2026-08-20
Director share, 12m
100.0%
of transactions where role is stated
Current run
6 sells
consecutive same-direction transactions
Net 3m flow
-$936.6K
purchases minus sales
Total on record
6

Transactions

6 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-08-202026-08-200AGGARWAL VIJAYDirectorGrant or award69,252$0.00filing
2026-08-202026-08-200Burnell Thomas W.Director, ChairmanGrant or award554,018$0.00filing
2026-08-202026-08-200Burnell Thomas W.Director, ChairmanExercise of derivative1,966,763$0.00filing
2026-08-202026-08-200Burnell Thomas W.Director, ChairmanShares withheld for tax581,718$1.61$936.6Kfiling
2026-08-202026-08-200Burnell Thomas W.Director, ChairmanExercise of derivative1,966,763$0.00filing
2026-08-202026-08-200Burnell Thomas W.Director, ChairmanGrant or award1,966,763$0.00filing

Source: U.S. Securities and Exchange Commission, EDGAR